P/E ratio for HealthEquity (HQY)
P/E ratio as of March 2023 (TTM): -82.6
According to HealthEquity's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -82.5857. At the end of 2021 the company had a P/E ratio of -632.
P/E ratio history for HealthEquity from 2014 to 2022
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2021 | -632 | -141.05% |
| 2020 | > 1000 | 1729.35% |
| 2019 | 84.2 | 52.4% |
| 2018 | 55.2 | -11.22% |
| 2017 | 62.2 | -33.98% |
| 2016 | 94.2 | 1.49% |
| 2015 | 92.9 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 FirstCash FCFS | 17.2 | -120.83% | 🇺🇸 USA |
 Amerco UHAL | 9.61 | -111.64% | 🇺🇸 USA |
 Green Dot GDOT | 13.6 | -116.48% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.